Dynavax Competitors
| DVAX Stock | USD 11.84 0.04 0.34% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Dynavax Technologies competition on your existing holdings.
Dynavax |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dynavax Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dynavax Technologies Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Dynavax Technologies and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Dynavax and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Dynavax Technologies does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dynavax Stock performing well and Dynavax Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dynavax Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | 1.77 | (0.34) | 0.00 | (0.10) | 0.00 | 2.79 | 21.89 | |||
| NBIX | 1.12 | (0.04) | 0.00 | 0.36 | 0.00 | 2.51 | 6.58 | |||
| ITCI | 2.17 | 0.17 | 0.07 | 0.23 | 2.31 | 3.70 | 29.40 | |||
| DCPH | 2.23 | (0.05) | 0.01 | 0.05 | 2.46 | 4.84 | 17.94 | |||
| AQST | 4.81 | 0.99 | 0.19 | 0.47 | 4.55 | 14.80 | 35.59 | |||
| AMPH | 1.70 | (0.44) | 0.00 | 0.88 | 0.00 | 3.10 | 18.07 | |||
| LNTH | 1.87 | 0.26 | 0.07 | (1.39) | 2.00 | 2.94 | 18.94 | |||
| ANIP | 1.32 | 0.20 | 0.13 | 0.33 | 1.22 | 2.58 | 14.17 | |||
| IRWD | 2.50 | (0.46) | 0.00 | 0.79 | 0.00 | 3.82 | 41.66 | |||
| PCRX | 1.60 | (0.35) | 0.00 | (0.36) | 0.00 | 2.64 | 10.08 |
Cross Equities Net Income Analysis
Compare Dynavax Technologies and related stocks such as Alkermes Plc, Neurocrine Biosciences, and Intracellular Th Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | (8.1 M) | (113.7 M) | 25 M | 17.6 M | (30.1 M) | (227.2 M) | (208.4 M) | (157.9 M) | (139.3 M) | (196.6 M) | (110.9 M) | (48.2 M) | (158.3 M) | 355.8 M | 373.5 M |
| NBIX | 5.9 M | 37.6 M | 5 M | (46.1 M) | (60.5 M) | (88.9 M) | (141.1 M) | (142.5 M) | 21.1 M | 37 M | 407.3 M | 89.6 M | 154.5 M | 249.7 M | 262.2 M |
| ITCI | 11.1 M | 11.1 M | (16.6 M) | (26.9 M) | (30.7 M) | (104.8 M) | (116.4 M) | (97.8 M) | (155.1 M) | (147.7 M) | (227 M) | (284.1 M) | (256.3 M) | (139.7 M) | (146.7 M) |
| AMPH | 7.8 M | 7.8 M | 18.1 M | 11.9 M | (10.7 M) | (2.8 M) | 10.5 M | 4.5 M | (5.7 M) | 48.9 M | 1.1 M | 62.1 M | 91.4 M | 137.5 M | 144.4 M |
| LNTH | (137.3 M) | (137.3 M) | (42 M) | (61.6 M) | (3.6 M) | (14.7 M) | 26.8 M | 123.4 M | 40.5 M | 31.7 M | (13.5 M) | (71.3 M) | 28.1 M | 326.7 M | 343 M |
| IRWD | (52.8 M) | (64.9 M) | (72.6 M) | (272.8 M) | (189.6 M) | (142.7 M) | (81.7 M) | (116.9 M) | (282.4 M) | (15.3 M) | 106.2 M | 528.4 M | 175.1 M | (1 B) | (952.1 M) |
| PCRX | (41.9 M) | (43.3 M) | (52.3 M) | (63.9 M) | (13.7 M) | 1.9 M | (37.9 M) | (42.6 M) | (471 K) | (11 M) | 145.5 M | 42 M | 15.9 M | 42 M | 44.1 M |
| EGRX | (19.4 M) | (19.4 M) | (19.4 M) | (6 M) | (18 M) | 2.6 M | 81.5 M | 51.9 M | 31.9 M | 14.3 M | 12 M | (8.6 M) | 35.6 M | 41 M | 43 M |
| EBS | (554 K) | 23 M | 23.5 M | 31.1 M | 36.7 M | 62.9 M | 51.8 M | 82.6 M | 62.7 M | 54.5 M | 305.8 M | 219.5 M | (223.8 M) | (257.4 M) | (244.5 M) |
| DRRX | (8.7 M) | (18.8 M) | 16.2 M | (21.5 M) | (22.1 M) | (22.7 M) | (34.5 M) | (3.7 M) | (25.3 M) | (22.8 M) | (2.5 M) | (38.1 M) | (35.6 M) | (27.6 M) | (29 M) |
Dynavax Technologies and related stocks such as Alkermes Plc, Neurocrine Biosciences, and Intracellular Th Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Dynavax Technologies financial statement analysis. It represents the amount of money remaining after all of Dynavax Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Dynavax Technologies Competitive Analysis
The better you understand Dynavax Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Dynavax Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Dynavax Technologies' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Dynavax Technologies Competition Performance Charts
Five steps to successful analysis of Dynavax Technologies Competition
Dynavax Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Dynavax Technologies in relation to its competition. Dynavax Technologies' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Dynavax Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Dynavax Technologies' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Dynavax Technologies, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Dynavax Technologies position
In addition to having Dynavax Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Dynavax Technologies Correlation with its peers. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.